The for-profit hospital operator recorded revenues of $3.2 billion in the second quarter of this year, up 17.1 percent compared to the same period in 2020.
After factoring in operating expenses totaling about $2.8 billion, UHS recorded an operating income of $439 million in the quarter ending June 30. In the same quarter last year, UHS recorded an operating income of $358 million.
The hospital operator ended the second quarter of 2021 with a $325 million profit, up 29 percent from the $251.9 million recorded in the same quarter last year.
UHS also authorized a $1 billion increase to its previously announced stock repurchase program. The health system will increase the amount it will buy back to $3.7 billion, up from $2.7 billion. Since the program began in 2014, UHS has repurchased 20 million shares for $2.5 billion.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
